Overview
Francisco Segura-Giner practices practicing medicine in Valencia, Spain.
His clinical expertise encompasses Pseudomyxoma Peritonei, Appendix Cancer, and Osteosarcoma.
He is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Francisco Segura-Giner
Is Francisco Segura-Giner a top-rated expert for Pseudomyxoma Peritonei?
MediFind is an objective health platform that identifies experts based on real-world data. Francisco Segura-Giner is classified as an Experienced expert for Pseudomyxoma Peritonei, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Francisco Segura-Giner participate in research or clinical trials?
Yes. Francisco Segura-Giner has published 8 articles and abstracts on conditions like Pseudomyxoma Peritonei. You can view a list of Francisco Segura-Giner's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Appendix CancerMr. Segura-Giner isExperienced. Learn about Appendix Cancer.
- OsteosarcomaMr. Segura-Giner isExperienced. Learn about Osteosarcoma.
- Pseudomyxoma PeritoneiMr. Segura-Giner isExperienced. Learn about Pseudomyxoma Peritonei.